BCL2L1 and melanoma: By using in vivo zebrafish model, we previously evidenced the role of Bcl-xL in sustaining and inducing melanoma aggressiveness, via an autocrine pathway involving IL-8 and its receptor C-X-C motif chemokine receptor 2 (CXCR2).